Theravance Biopharma, Inc. (TBPH) Q2 2019 Earnings Call Transcript
TBPH earnings call for the period ending June 30, 2019.
Theravance Biopharma
TBPH
TBPH
$17.18
$0.18
1.1%
BATS BZX Real Time Price as of October 17, 2019, 4:00 p.m. EDT
View Interactive TBPH Charts
Theravance Biopharma, Inc. - Ordinary Shares
News & Analysis: Theravance Biopharma
Theravance Biopharma Inc. (TBPH) Q1 2019 Earnings Call Transcript
TBPH earnings call for the period ending March 31, 2019.
Theravance Biopharma Inc (TBPH) Q4 2018 Earnings Conference Call Transcript
TBPH earnings call for the period ending December 31, 2018.
Why Theravance Biopharma Inc Shares Tumbled 19.5% Today
Theravance Biopharma announced a stock and debt offering that disappointed investors.
Theravance Biopharma Inc Skyrocketed in October -- Here's Why
A slew of good news sends shares skyward. So what was announced that got investors so excited?
Why Theravance Biopharma Inc. Fell 20% in September
Despite releasing some good news, a rough month for biotech stocks in general crushed the company's stock.
Why Theravance Biopharma Inc Shares Soared Today
Theravance Biopharma announced that Mylan Inc. has agreed to co-develop TD-4208 and make an equity investment in the company.
This COPD Investment Opportunity Isn't What It Seems
Theravance's new structure may surprise investors looking for a pure play.
Shorts Are Piling Into These Stocks; Should You Be Worried?
Do short-sellers have these three stocks pegged? You be the judge!
